CoChat

Sodium Oligomannate: First Approval

Syed, Yahiya Y. · 2020 · Drugs

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Sodium oligomannate ( ® ; GV-971) is a marine algae-derived oral oligosaccharide being developed by Shanghai Green Valley Pharmaceuticals for the treatment of Alzheimer's disease (AD). Sodium oligomannate received its first approval in November 2019 in China for the treatment of mild to moderate AD to improve cognitive function. This article summarizes the milestones in the development of sodium oligomannate leading to this first approval for AD.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40265-020-01268-1

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 7 references

Research works printed but not linked: 2

  1. Xiao S. A phase II clinical trial on GV-971 in patients with Alzheimer’s [abstract no. OC 3]. J Prev Alz Dis. 2014;1(3):214–96.
  2. Shi-fu X. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer disease [abstract]. Chin J Pharmacol Toxicol. 2019;6(6):403.

Cited by

See all 190

Metadata

Authors
Syed, Y. Y.
Affiliations
Springer Nature (New Zealand) (NZ)
Corresponding author
Syed, Yahiya Y.
Venue
Drugs
Published
2020-02-04
Volume
80
Issue
4
Pages
441-444
ISSN
  • 0012-6667 (ISSN-L)
  • 1179-1950
OpenAlex
W3005220370
Cited by
187
References
7
Citations by year
2026: 23 · 2025: 29 · 2024: 33 · 2023: 32 · 2022: 38 · 2021: 15 · 2020: 17
FWCI
15.78
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, drug approval, cognitive function, drug development milestones
MeSH terms
Alzheimer Disease, Animals, China, Humans, Mannose, Oligosaccharides, Drug Approval

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sodium Oligomannate: First Approval. https://app.cochat.ai/papers/10.1007/s40265-020-01268-1
The paper
Syed, Y. Y. (2020). Sodium Oligomannate: First Approval. Drugs. https://doi.org/10.1007/s40265-020-01268-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.